Abstracts tagged "Assessment"

Abstract Number: 2299 • 2013 ACR/ARHP Annual Meeting
Disease Activity Scoring: Comparing Patient and Physician Global Assessment Of Disease Activity In Rhumatoid Arthritis Patients Starting a First Biologic Agent
Boulos Haraoui¹, Louis Bessette², Diane Sauvageau¹, Jean Pierre Pelletier³, Jean-Pierre Raynauld¹, Edith Villeneuve¹, Louis Coupal³ and Denis Choquette³, ¹Rheumatology, Institut de Rhumatologie de Montréal, Montreal, QC, Canada, ²Centre Hospitalier Universitaire de Québec, pavillon CHUL, Sainte-Foy, QC, Canada, ³Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada
Background/Purpose: Visual analogue scales (VAS) are routinely used in daily clinical practice and are part of the different composite outcome measures such as the DAS,…
Abstract Number: 2252 • 2013 ACR/ARHP Annual Meeting
Assessment Of Rheumatoid Arthritis Disease Activity By Patients and Physicians: Do Physicians Detect Improvement Before The Patient Does?
William G. Bensen¹, J. Carter Thorne², Philip Baer³, Andrew Chow⁴, Regan Arendse⁵, Isabelle Fortin⁶, Milton F. Baker⁷, Boulos Haraoui^8,9, Algis Jovaisas¹⁰, John S. Sampalis^11,12, Emmanouil Rampakakis^11,12, Allen J. Lehman¹³, Francois Nantel¹⁴, May Shawi¹⁵ and Susan M. Otawa¹³, ¹Department of Medicine, Division of Rheumatology, Clinical Professor, McMaster University, Hamilton, ON, Canada, ²Southlake Regional Health Centre, Newmarket, ON, Canada, ³Private Practice, Scarborough, ON, Canada, ⁴University of Toronto, McMaster University, Credit Valley Rheumatology, Mississauga, ON, Canada, ⁵University of Saskatchewan, Saskatoon, SK, Canada, ⁶Centre de rhumatologie de l'est du Québec (CREQ), Rimouski, QC, Canada, ⁷University of Victoria, Victoria, BC, Canada, ⁸Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, ⁹Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada, ¹⁰Division of Rheumatology, University of Ottawa, Ottawa, ON, Canada, ¹¹JSS Medical Research, Montreal, QC, Canada, ¹²Jewish General Hospital, McGill University, Montreal, QC, Canada, ¹³Medical Affairs, Janssen Inc., Toronto, ON, Canada, ¹⁴Janssen Inc., Toronto, ON, Canada, ¹⁵Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada
Background/Purpose: Patient (PtGA) and physician (MDGA) global assessment of disease activity measure the same construct from two different perspectives. The objective of this study was…
Abstract Number: 2246 • 2013 ACR/ARHP Annual Meeting
Patients’ Assessment of the Disease Greatly Influences the Determination of Disease Activity and Remission in Rheumatoid Arthritis
Kenrin Shi^1,2, Kenji Miki^1,3, Masao Yukioka¹, Kosuke Ebina², Shoichi Kaneshiro² and Hideki Yoshikawa², ¹Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan, ²Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Japan, ³Department of Orthopaedic Surgery, Amagasaki Central Hospital, Amagasaki, Japan
Background/Purpose: Recently defined remission criteria of rheumatoid arthritis (RA), Boolean criteria or Simplified Disease Activity Index (SDAI)
Abstract Number: 2177 • 2013 ACR/ARHP Annual Meeting
A Pilot Study Of Juvenile Localized Scleroderma (jLS) Consensus Treatment Plans
Suzanne C. Li¹, Kathryn S. Torok², Mara L Becker³, Fatma Dedeoglu⁴, Robert C. Fuhlbrigge⁵, Gloria C. Higgins⁶, Sandy D. Hong⁷, Maria F. Ibarra⁸, Ronald M. Laxer⁹, Thomas G. Mason II¹⁰, Elena Pope¹¹, Marilynn G. Punaro^12,13, C. Egla Rabinovich¹⁴, Katie G. Stewart¹², Christina Kelsey¹⁵, Brian Feldman¹⁶, Themba Nyrienda¹⁷ and Knut M. Wittkowski¹⁸, ¹Pediatrics, Joseph M Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack, NJ, ²Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ³Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, ⁴Division of Immunology, Boston Children's Hospital, Boston, MA, ⁵Pediatric Rheumatology, Childrens Hospital, Boston, MA, ⁶Pediatric Rheumatology Ohio State University, Nationwide Childrens Hosp, Columbus, OH, ⁷Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA, ⁸Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, ⁹Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁰Rheumatology, Mayo Clinic Rochester, Rochester, MN, ¹¹Dermatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹²Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, ¹³Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, ¹⁴Duke University Medical Center, Durham, NC, ¹⁵Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ¹⁶Rheumatology, Hospital for Sick Kids, Toronto, ON, Canada, ¹⁷Research, Hackensack University Medical Center, Hackensack, NJ, ¹⁸Center for Clinical and Translational Science, Rockefeller University, New York, NY
Background/Purpose: Purpose: To evaluate clinical assessment tools and standardized treatment regimens (consensus treatment plans, CTPs) developed for juvenile localized scleroderma (jLS) jLS is a chronic, inflammatory…
Abstract Number: 1527 • 2013 ACR/ARHP Annual Meeting
Routine Assessment Of Patient Index Data 3 Scores Correlate Well With Bath Ankylosing Spondylitis Disease Activity Index In The Assessment Of Disease Activity and Monitoring Progression Of Ankylosing Spondylitis
Abhijeet Danve¹, Kiana Vakil-Gilani², Anusha Reddy², Annan Sheffield³, Alexis Dinno⁴ and Atul A. Deodhar⁵, ¹Rheumatology, Oregon Health and Science University, Portland, OR, ²Arthritis and Rheumatic diseases, Oregon Health and Science University, Portland, OR, ³Portland State University, Portland, OR, ⁴School of Community Health, Portland State University, Portland, OR, ⁵Oregon Health and Science University, Portland, OR
Background/Purpose: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is a composite tool unique to measure disease activity in ankylosing spondylitis (AS) just as Disease Activity…
Abstract Number: 1225 • 2013 ACR/ARHP Annual Meeting
FRAX 10-Year Fracture Risk In Women With a Fracture Of The Distal Forearm: Agreement Between Assessments With and Without Bone Mineral Density and Influence Of Measurement Side In Individual Patients
Emilie Egsmose¹, Mette Birkvig², Thora Buhl³ and Ole Rintek Madsen³, ¹Copenhagen University Hospital Hvidovre, Copenhagen, Denmark, ²Osteoporosis Clinic, Copenhagen University Hospital Gentofte, Copenhagen, Denmark, ³Copenhagen University Hospital Gentofte, Copenhagen, Denmark
Background/Purpose: The FRAX® tool has been developed by WHO to evaluate fracture (Fx) risk of patients. It is based on individual patient models that integrate…
Abstract Number: 991 • 2013 ACR/ARHP Annual Meeting
Utilization Of An Informational Needs Assessment To Develop An Education Program For Patients With Ankylosing Spondylitis (AS) and Related Axial Spondyloarthritis (SpA)
Rita Kang¹, Rebecca Morton², Christopher Hawke³, Laura A. Passalent⁴, Robert D. Inman^5,6, Dinny Wallis⁷, Joan Blair³, Alison Lake⁸, Heather Sloman⁸, Marc Doucet⁹, Debra MacGarvie⁸ and King Wong⁹, ¹Patient Education, University Health Network- Toronto Western Hospital, Toronto, ON, Canada, ²Allied Health/Rheumatology, University Health Network- Toronto Western Hospital, Toronto, ON, Canada, ³Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁴Allied Health, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁵Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, ⁶U of Toronto, Toronto, ON, Canada, ⁷Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁸University Health Network- Toronto Western Hospital, Toronto, ON, Canada, ⁹University Health Network, Toronto, ON, Canada
Background/Purpose: The effectiveness of education programs for patients with arthritis has been well documented. Despite this, there has been minimal investigation into patient education specifically…
Abstract Number: 844 • 2013 ACR/ARHP Annual Meeting
Level and Determinants Of Health Related Quality Of Life In Childhood-Onset Systemic Lupus Erythematosus
Jordan T. Jones¹, Shannen L. Nelson², Janet Wootton³, Brianna Liberio⁴, Alexandria J. Greenler⁵, Jennifer L. Huggins¹, Laura E. Schanberg⁶ and Hermine Brunner¹, ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, ³Pediatric Rheumatology, Duke University Medical Center, Durham, NC, ⁴University of Cincinnati College of Medicine, Cincinnati, OH, ⁵Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁶Pediatrics, Duke University Medical Center, Durham, NC
Background/Purpose: Childhood-onset lupus (cSLE) is a chronic autoimmune disease and its effect on health-related quality of life (HRQoL) has not been systematically established, nor does…
Abstract Number: 2584 • 2012 ACR/ARHP Annual Meeting
Quantitative and Semi-Quantitative Bone Erosion Assessment On High-Resolution Peripheral Quantitative Computed Tomography in Rheumatoid Arthritis
Waraporn Srikhum¹, Warapat Virayavanich¹, Andrew J. Burghardt², Andrew Yu¹, Thomas M. Link¹, John B. Imboden³ and Xiaojuan Li⁴, ¹Musculoskeletal Quantitative Imaging Research Group, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, ²Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA, ³Department of Medicine, Division of Rheumatology, UCSF, San Francisco, CA, ⁴Department of Radiology and Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA
Background/Purpose: The goals of this project were (i) to develop novel quantitative and semiquantitative measures of bone erosions at the metacarpophalangeal (MCP) and wrist joints…
Abstract Number: 245 • 2012 ACR/ARHP Annual Meeting
Similarities of Patient Self-Report Scores From a Multidimensional Health Assessment Questionnaire (MDHAQ), Laboratory Tests, Physician Global Assessment, and Polyarticular Involvement in Patients with Osteoarthritis and Rheumatoid Arthritis
Isabel Castrejón¹, Yusuf Yazici² and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, NYU Hospital for Joint Diseases, New York, NY
Background/Purpose: Rheumatoid arthritis (RA) and osteoarthritis (OA) are distinct diagnoses, based on widely differing pathogenetic mechanisms and treatments. However, OA patients may experience functional disability,…
Abstract Number: 2363 • 2012 ACR/ARHP Annual Meeting
Assessment of Disease Activity in Large Vessel Vasculitis: Initial Results of an International Delphi Exercise
Sibel Z. Aydin¹, Haner Direskeneli², Eric L. Matteson³ and Peter A. Merkel⁴, ¹Unit of Rheumatology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey, ²Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, ³Rheumatology, Mayo Clinic, Rochester, MN, ⁴University of Pennsylvania, Philadelphia, PA
Background/Purpose: Assessment of disease activity in large vessel vasculitis (LVV) is challenging. The lack of specific, validated outcome measurements for both Takayasu’s (TAK) and giant…
Abstract Number: 129 • 2012 ACR/ARHP Annual Meeting
Comparison of Automated, Computer-Based Assessment and Visually Assessed Disease Activity Scores in ICG-Enhanced Fluorescence Optical Imaging in Patients with Rheumatic Disorders: A Feasibility Study
Stephanie G. Werner¹, Michael Schirner², Hans-Eckhard Langer³, Mathias Cziumplik², Jörn Berger², Marina Backhaus¹ and Malte Bahner², ¹Rheumatology/Immunology, Charite University Hospital, Berlin, Germany, ²mivenion GmbH, Berlin, Germany, ³RHIO (Rheumatology, Immunology, Osteology) Duesseldorf, Duesseldorf, Germany
Background/Purpose: Modern diagnostic imaging technologies including US and MRI become increasingly important in the management of rheumatic joint disorders. Semiquantitative scores, like the RAMRIS or…
Abstract Number: 2104 • 2012 ACR/ARHP Annual Meeting
Quantitation in Patients with Rheumatoid Arthritis of Inflammation, Joint Damage and “Unexplained Symptoms” (e.g., Fibromyalgia) in Addition to Overall Status, According to 4 Physician Global Estimates Scored 0-10
Isabel Castrejón¹, Martin J. Bergman² and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Taylor Hospital, Ridley Park, PA
Background/Purpose: A physician global estimate (DOCGL) of patient clinical status in rheumatoid arthritis (RA) is scored by many rheumatologists entirely based on inflammation, but others…
Abstract Number: 96 • 2012 ACR/ARHP Annual Meeting
Quality of Care: Reference and Counter Reference From Family Physicians and Rheumatologists’ perspectives– A Pilot Study
Thiago D. Baumgratz¹, Raphael Battisti¹, Mirella Cuziol², Ana Carolina Reiff Janini², R.A. Levy³ and Mirhelen M. Abreu⁴, ¹Medical Student at Universidade Federal de São Carlos, São Carlos, Brazil, ²Medicine, Medical Student at Universidade Federal de São Carlos, São Carlos, Brazil, ³Hospital Universitário Pedro Ernesto, Rio de Janeiro, Brazil, ⁴Universidade Federal de São Carlos, São Carlos SP, Brazil
Background/Purpose: We delineated family physicians' and rheumatologists’ point of view when primary care is facing cases of rheumatic diseases. We also tried to identify barriers…
Abstract Number: 2108 • 2012 ACR/ARHP Annual Meeting
Identification of Four Parameters That Drive the Discordance Between the Patient and Physician Global Assessment in Rheumatoid Arthritis
William Bensen¹, Denis Choquette², Milton F. Baker³, Susan M. Otawa⁴ and Hayssam Khalil⁴, ¹St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, ²Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, ³University of Victoria, Victoria, BC, Canada, ⁴Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada
Background/Purpose: Patient (PtGA) and physician (MDGA) global assessment of disease activity are standard outcome measures used to ascertain physician and patient subjective perception of disease…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].